Francesco Massari

2 ta ish

Azienda USL di Bologna

1. Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

   Matteo Santoni, Sebastiano Buti, Zin Myint +63

   Maqola20233 iqtibos

   ABIABI:AkademIndex/2026.other.839256

2. Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma

   Matteo Santoni, Francesco Massari, Consuelo Amantini +8

   Sharh maqola20132 iqtibos

   ABIABI:AkademIndex/2026.other.744010